Status:
COMPLETED
Assessment of Tramadol as a Treatment for Opioid Addiction
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
21-55 years
Phase:
PHASE1
PHASE2
Brief Summary
Opioids are one of the most commonly abused drugs among individuals who seek treatment for drug abuse. Thus, it is necessary to develop new treatments for opioid addiction. The purpose of this trial i...
Detailed Description
This human laboratory study will test the effects of tramadol as a step in its development as a new treatment for opioid dependence. Tramadol is a moderate mu agonist opioid that may produce low level...
Eligibility Criteria
Inclusion
- Currently opioid dependent
Exclusion
- Significant medical illness (e.g., diabetes mellitus)
- History of seizure
- Current sedative or alcohol dependence
- Pregnant or breastfeeding
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00301210
Start Date
January 1 2006
End Date
November 1 2007
Last Update
April 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Behavioral Pharmacology Research Unit
Baltimore, Maryland, United States, 21224